Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multisystem Atrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06890390
What this trial is testing

TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Not applicableStudy completedNCT05807373
What this trial is testing

Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis - Part 2

Who this might be right for
Parkinson DiseaseMultiple System Atrophy
University Hospital, Bordeaux 28
Testing effectiveness (Phase 2)Study completedNCT04184063
What this trial is testing

Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

Who this might be right for
Progressive Supranuclear PalsyMultiple System Atrophy
EmeraMed 20
Large-scale testing (Phase 3)Looking for participantsNCT07446894
What this trial is testing

MSA-01 in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Tokyo University 140
Not applicableLooking for participantsNCT06596746
What this trial is testing

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseSynucleinopathies+15 more
Casa di Cura San Raffaele Cassino 600
Not applicableStudy completedNCT03120013
What this trial is testing

Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia

Who this might be right for
Ataxia, CerebellarCerebellar AtaxiaSpinocerebellar Ataxias+8 more
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 21
Not applicableEnrolling By InvitationNCT04680130
What this trial is testing

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Who this might be right for
PSPCBDPCA+9 more
Mayo Clinic 500
Not applicableLooking for participantsNCT03312556
What this trial is testing

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Who this might be right for
Supine HypertensionAutonomic Failure
Vanderbilt University Medical Center 12
Not applicableStudy completedNCT01044992
What this trial is testing

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

Who this might be right for
Multisystemic Atrophy
University Hospital, Toulouse 38
Not applicableLooking for participantsNCT06174948
What this trial is testing

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Who this might be right for
Parkinson's Disease and ParkinsonismProgressive Supranuclear PalsyDifferent Types of Tremor Including Essential Tremor+5 more
Queen Mary University of London 70
Early research (Phase 1)WithdrawnNCT01119417
What this trial is testing

The Role of Endothelin in the Supine Hypertension of Autonomic Failure

Who this might be right for
HypertensionPure Autonomic FailureMultiple System Atrophy
Vanderbilt University
Not applicableStudy completedNCT05889260
What this trial is testing

Speech Accessibility Project

Who this might be right for
Parkinson DiseaseProgressive Supranuclear PalsyMultiple System Atrophy+1 more
University of Illinois at Urbana-Champaign 485
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Not applicableStudy completedNCT06738862
What this trial is testing

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

Who this might be right for
α-synucleinopathyParkinson's Disease (PD)Multiple System Atrophy+2 more
Ruijin Hospital 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02315027
What this trial is testing

Mesenchymal Stem Cell Therapy in Multiple System Atrophy

Who this might be right for
MSA
Mayo Clinic 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07518810
What this trial is testing

Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Second Affiliated Hospital, Zhejiang University, School of Medicine 150
Not applicableStudy completedNCT03577483
What this trial is testing

Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis

Who this might be right for
Parkinson DiseaseMSA - Multiple System Atrophy
University Hospital, Bordeaux 68
Not applicableStudy completedNCT04858893
What this trial is testing

Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms

Who this might be right for
Primary ParkinsonismSecondary Vascular Parkinson DiseaseMultiple System Atrophy+1 more
Ospedale Generale Di Zona Moriggia-Pelascini 562
Not applicableActive Not RecruitingNCT05913687
What this trial is testing

Automated Imaging Differentiation of Parkinsonism

Who this might be right for
Parkinson DiseaseMultiple System Atrophy, Parkinson VariantProgressive Supranuclear Palsy
University of Florida 315
Early research (Phase 1)Looking for participantsNCT04165486
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)

Who this might be right for
Multiple System Atrophy
Ionis Pharmaceuticals, Inc. 40
Next Page